2nd Annual Research Symposium

October 2018

Jean-Frederic Colombel MD

The Mount Sinai Hospital

Key Note Address:

The Spirit of Collaboration: From GETAID to NYCCO

Jordan Axelrad MD

NYU Langone Medical Center

Risk of New or Recurrent Cancer in Patients With IBD and Previous Cancer

Galen Leung MD

Stonybrook University Medical Center

Managing Infliximab Re-introduction after Temporary Discontinuation of Drug: a Retrospective Multicentric Study

Keith Sultan MD

Northwell Health

Utilization of Serologic and Genetic Testing in the Diagnosis and Management of IBD: A Physician Survey

Robert Hirten MD

The Mount Sinai Hospital

Anastomotic Ulcers After Ileocolic Resection Predict Crohn's Disease Recurrence

Ryan Ungaro MD

The Mount Sinai Hospital

Stopping 5-Aminosalicylates in IBD Patients Starting Biologic Therapy Does Not Increase the Risk of Adverse Clinical Outcomes: Analysis of Two Nationwide of Population-Based Cohorts

Adam Tepler MD

Montefiore Medical Center

The Impact of Delay in Clostridium difficile Testing on Outcomes in IBD Patients Hospitalized with Gastrointestinal Symptoms

Qin Rao MD

Stonybrook University Medical Center

A Study of the Risk Factors for Hospital Admissions in IBD and the Differences between Crohn’s Disease and Ulcerative Colitis Admissions in a Large Tertiary Care Center